Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab Plus GM-CSF in Follicular B-Cell Lymphoma
NCT01939730Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 1999
- Primary completion
- Dec 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in follicular lymphoma (FL), sponsored by University of Texas MD Anderson Cancer Center. Started Aug 1999; status: completed.
02
Drugs
sargramostim
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT01939730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01939730.